Proceedings of the National Academy of Sciences publishes article on
Swedish method for treating anorexia and bulimia

Press conference at 1:00 p.m., June 25, at Anorexicentrum (Center of
Eating Disorders), 4th floor, Novums Forskningspark (Novum Research
Park), Huddinge (Stockholm).

An article about a Swedish method for treating the eating disorders
anorexia and bulimia is being published Tuesday, June 25 in the
Proceedings of the National Academy of Sciences (PNAS) in the United
States.

The method, developed at the Center for Eating Disorders in Sweden and
the Section of Applied Neuroendocrinology of Karolinska Institutet at
the Novum Research Park in Huddinge (Stockholm), has proven to be a very
effective treatment for anorexia and bulimia. In studies performed on 16
randomly selected patients affected by anorexia or bulimia, which were
compared with 16 untreated patients, 14 of the treated patients were
cured, compared with only one of the untreated patients. Anorexia and
bulimia were previously considered difficult to treat.

The treatment, which uses a patented computer-based system to help
patients adapt their eating behavior to normal curves, and keeps their
physical activity to a minimum, has already treated 130 patients
successfully. Of all patients treated to date with Mandometer, a
computer-based software for relearning eating habits, 75 percent have
recovered and 12 percent have noted a significant improvement in their
condition. Only 7 percent of treated patients had relapses. In addition
to following the Mandometer program, patients are treated with heat to
reduce their activity and they learn social behavior. Based on
calculations, use of the Mandometer method achieves considerable savings
in hospital budgets and reduces indirect costs for society.

The treatment was started by Cecilia Bergh, who became interested in
eating disorders in the beginning of the 1980s and received a Ph.D for
her dissertation on bulimia nervosa. Cecilia Bergh developed the
Mandometer Treatment together with Professor Per Södersten, Head of the
Section of Applied Neuroendocrinology at Karolinska Institutet.

Read more about the Mandometer Treatment at: www.mando.se

For further information:

Cecilia Bergh, Managing Director, +46 8 556 406 01.
Jan Ejderhamn, Clinical Director, +46 8 556 406 06.
Per Södersten, Director of Research, +46 8 556 406 02.